Evidence map›Paper›PMID 29899094›Full record

ArticleJournal of virology2018

Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones.

Arumugam Balamurugan, Hwee L Ng, Otto O Yang

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. T cell-based strategies for HIV-1 vaccines.Human vaccines & immunotherapeutics · 2020
    Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Arumugam BalamuruganDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California USA.
Hwee L NgDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California USA.
Otto O YangDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California USA oyang@mednet.ucla.edu.

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Dissection of HIV-1 CTL Escape PathwaysR01DE025166 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, OTTO O · 2014 to 2018
$2.1M
NIAID NIH HHS P30 AI028697NIDCR NIH HHS R01 DE025166
6 · The paper itself

Abstract

Although a high level of promiscuity for heterologous epitopes is believed to exist for cellular immunity, limited data explore this issue for human immunodeficiency virus type 1 (HIV-1)-specific CD8

Indexed as

Cross ReactionsImmunity, HeterologousCells, CulturedEpitopes, T-LymphocyteGenotypeHistocompatibility Antigens Class IHIV-1HIV InfectionsHumansT-Lymphocytes, CytotoxicEpitopes, T-LymphocyteHistocompatibility Antigens Class Icross-reactivitycytotoxic T lymphocyteHIV

Identifiers

PMID29899094
PMCPMC6069174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.